RUNX1 mutations have frequently been identified in a variety of hematological malignancies, including AML, MDS, MPN, and acute lymphoblastic leukemia (ALL) [4,5,6,7,8,9,10,59,60,61,62,63]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.